leisure time -WSS

leisure time

author：comprehensive 2025-09-06 03:30:53 - browse：7865

Adobe

At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the Food and Drug Administration announced in a recall notice on Wednesday.

The product is made by Tandem Diabetes Care, which sells touchscreen insulin pumps and an accompanying app to help dose the medicine. Around 300,000 people use the technology. Tandem found that a bug in the app’s software is causing the app to repeatedly crash and relaunch, draining the insulin pump’s battery through unnecessary Bluetooth communication.

An insulin pump shutting down unexpectedly could kill people, especially if the shutdown occurs while the person is sleeping. There have been no reports of death so far, the FDA said. Tandem users commiserated over the issue on Reddit two months ago, with one user describing waking up at 2 a.m. to a dead pump. “Infuriating,” the user wrote. “Absolutely should be sending a notice out to all customers about this.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Why failed clinical trials don’t always spell doom for a new drug

WSS

Drastic changes should bring profitability, startup health insurers say

Data show record exodus of life scientists from academia

Drastic changes should bring profitability, startup health insurers say

A biotech analyst on neuroscience, placebo effect, not over

FDA panel issues narrow recommendation for Covid vaccine booster doses

Maui's cultural, historic landmarks damaged in the devastating wildfires

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Moonlake's readout produced a cash windfall. Risks remain

Mindstrong's demise and the future of mental health care

Sports medicine is finally prioritizing gender equality

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Wildfire smoke exposes gaps in outdoor worker protections

Paxlovid should be available without a positive Covid test

Anesthesiologist group: stop taking Ozempic before surgery

Menendez indictment could see pharma lose a key ally

Wildfire smoke exposes gaps in outdoor worker protections

Data show record exodus of life scientists from academia

hotspot

South Korea throws huge K

Address the ethical violations that led to 'Three Identical Strangers'

Methadone doses haven’t kept up in the age of fentanyl

Health tech startups drop sharply from 2021 highs

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

hotspot

entertainment

leisure time

leisure time